Sky Bear Technical Standards - Home
Search
×
FR

Placeholder headline

This is just a placeholder headline

ISO 7554-3:2026 Surgical instruments — Terms, measuring methods and test methods — Part 3: Test methods

$

192

BUY NOW

Placeholder headline

This is just a placeholder headline

ISO 41002:2026 Facility management — Development of the facility management organization

$

305

BUY NOW

Placeholder headline

This is just a placeholder headline

ISO 39004:2026 Road traffic safety — Good practice for service providers using digital platform

$

259

BUY NOW

ISO 24651:2022

ISO 24651:2022 Biotechnology – Biobanking – Requirements for human mesenchymal stromal cells derived from bone marrow

CDN $305.00

Description

This document specifies requirements for the biobanking of human mesenchymal stromal cells derived from bone marrow (hBM-MSCs), including the collection of bone marrow and associated data, isolation, culture, characterization, quality control, cryopreservation, storage, thawing, disposal, distribution and transport.

This document is applicable to all organizations performing biobanking with hBM-MSCs used for research.

This document does not apply to hBM-MSCs for the purpose of in vivo application in humans, cell therapy, clinical applications, tissue engineering or therapeutic use.

NOTE      International, national or regional regulations or requirements, or multiple of them, can also apply to specific topics covered in this document.

Edition

1

Published Date

2022-08-01

Status

PUBLISHED

Pages

27

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

This document specifies requirements for the biobanking of human mesenchymal stromal cells derived from bone marrow (hBM-MSCs), including the collection of bone marrow and associated data, isolation, culture, characterization, quality control, cryopreservation, storage, thawing, disposal, distribution and transport.

This document is applicable to all organizations performing biobanking with hBM-MSCs used for research.

This document does not apply to hBM-MSCs for the purpose of in vivo application in humans, cell therapy, clinical applications, tissue engineering or therapeutic use.

NOTE      International, national or regional regulations or requirements, or multiple of them, can also apply to specific topics covered in this document.

Previous Editions

Can’t find what you are looking for?

Please contact us at: